Kumar Sanni, Saxena Juhi, Srivastava Vijay Kumar, Kaushik Sanket, Singh Himadri, Abo-El-Sooud Khaled, Abdel-Daim Mohamed M, Jyoti Anupam, Saluja Rohit
Amity Institute of Biotechnology, Amity University Rajasthan, Amity Education Valley, Kant Kalwar, NH-11C, Jaipur Delhi Highway, Jaipur 303002, Rajasthan, India.
Department of Biotechnology, University Institute of Biotechnology, Chandigarh University, S.A.S Nagar 140413, Punjab, India.
Vaccines (Basel). 2022 Sep 20;10(10):1575. doi: 10.3390/vaccines10101575.
Oxidative stress resulting from the disproportion of oxidants and antioxidants contributes to both physiological and pathological conditions in sepsis. To combat this, the antioxidant defense system comes into the picture, which contributes to limiting the amount of reactive oxygen species (ROS) leading to the reduction of oxidative stress. However, a strong relationship has been found between scavengers of ROS and antioxidants in preclinical in vitro and in vivo models. ROS is widely believed to cause human pathology most specifically in sepsis, where a small increase in ROS levels activates signaling pathways to initiate biological processes. An inclusive understanding of the effects of ROS scavenging in cellular antioxidant signaling is essentially lacking in sepsis. This review compiles the mechanisms of ROS scavenging as well as oxidative damage in sepsis, as well as antioxidants as a potent therapeutic. Direct interaction between ROS and cellular pathways greatly affects sepsis, but such interaction does not provide the explanation behind diverse biological outcomes. Animal models of sepsis and a number of clinical trials with septic patients exploring the efficiency of antioxidants in sepsis are reviewed. In line with this, both enzymatic and non-enzymatic antioxidants were effective, and results from recent studies are promising. The usage of these potent antioxidants in sepsis patients would greatly impact the field of medicine.
氧化剂和抗氧化剂失衡所导致的氧化应激在脓毒症的生理和病理状况中均发挥作用。为应对这一情况,抗氧化防御系统开始发挥作用,它有助于限制活性氧(ROS)的量,从而减轻氧化应激。然而,在临床前的体外和体内模型中,已发现ROS清除剂与抗氧化剂之间存在紧密联系。人们普遍认为,ROS最特别地在脓毒症中引发人类病理状况,其中ROS水平的小幅升高会激活信号通路以启动生物学过程。脓毒症中基本上缺乏对细胞抗氧化信号传导中ROS清除作用的全面理解。本综述汇编了脓毒症中ROS清除机制以及氧化损伤,以及抗氧化剂作为一种有效治疗手段的情况。ROS与细胞通路之间的直接相互作用极大地影响脓毒症,但这种相互作用并未解释不同生物学结果背后的原因。本文回顾了脓毒症动物模型以及一些针对脓毒症患者探索抗氧化剂疗效的临床试验。与此相符的是,酶促和非酶促抗氧化剂均有效,近期研究结果很有前景。这些强效抗氧化剂在脓毒症患者中的应用将极大地影响医学领域。
Vaccines (Basel). 2022-9-20
Front Cell Infect Microbiol. 2024
Infect Disord Drug Targets. 2009-8
Infect Disord Drug Targets. 2012-4
Am J Physiol Lung Cell Mol Physiol. 2002-8
Int J Biochem Cell Biol. 2010-6-19
Eur J Med Res. 2025-8-31
J Inflamm Res. 2025-7-22
Mater Today Bio. 2025-7-4
Molecules. 2025-5-23
Antioxidants (Basel). 2025-2-18
Front Bioeng Biotechnol. 2020-7-23
Am J Physiol Lung Cell Mol Physiol. 2020-5-27
J Appl Physiol (1985). 2020-3-1
Oxid Med Cell Longev. 2019-10-24